ARCHIVES

Two Phase II Ibrutinib Studies Presented to EHA Demonstrate Efficacy as a Monotherapy

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

In Brief: NCI Recieves Two Proposals For Antineoplaston Trials, None For Children; Stubble Elected To NAS

June 19, 1992

New Patterns Of Care Study Okayed By DCT Board

June 13, 1986

In Brief: Oldham to Leave NCI, Herberman Acting Head Of BRMP; Lansky Appointed Director Of ICC

November 11, 1983

Afinitor and Sutent Approved For Pancreatic Neuroendocrine Tumors

May 27, 2011

NCI-Approved Protocols Listed

December 26, 2003

Breast MRI Recipients More Likely To Choose Mastectomy

July 31, 2009